Frontlight ResearchEarly access
CompletedNo phase
Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 1,200 people enrolled
- Started
- 29 Mar 2021
- Ended
- 31 Aug 2026
- Type of study
- Observational
- Record updated
- 4 September 2026
Who can take part
- Age
- 18 years to 79 years
- Sex
- Women and men
Show the full registry criteria (12)Hide the full registry criteria
Who can take part
- Arrival to the hospital within 6 hours of injury
- Age >= 18 years old
- Patients with traumatic brain injury(TBI). TBI is defined as any alteration or loss of consciousness with or without positive head C.T findings
Who cannot take part
- Any thoracic or abdominal injury resulting in open surgical intervention
- Age > 89 years
- Deemed to have a non-survivable TBI
- Brain dead on arrival
- Active substance abuse for opiates and cocaine as noted by admission toxicology screen
- Pregnancy
- Prisoners
- Active military
- Non - English speaking (due to necessity for consent in aims 2 and 3)
Where in United States
- University of Maryland Medical CenterBaltimore, United States
About the trial
What the trial wants to find out
This study will look to validate predictive algorithms developed in a previous study where we collected relevant data from trauma registry and after using advanced signal-processing and machine-learning, determined prediction scores regarding neuroworsening and other outcomes following traumatic brain injury.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Real Time Vital Sign Assessment to Predict Neurological Decline After Traumatic Brain Injury (RAPID-TBI)
- Record updated
- 4 September 2026